致命性新冠肺炎继发感染的宿主和微生物群特征
Host and microbiome features of secondary infections in lethal covid-19.
作者信息
Zacharias Martin, Kashofer Karl, Wurm Philipp, Regitnig Peter, Schütte Moritz, Neger Margit, Ehmann Sandra, Marsh Leigh M, Kwapiszewska Grazyna, Loibner Martina, Birnhuber Anna, Leitner Eva, Thüringer Andrea, Winter Elke, Sauer Stefan, Pollheimer Marion J, Vagena Fotini R, Lackner Carolin, Jelusic Barbara, Ogilvie Lesley, Durdevic Marija, Timmermann Bernd, Lehrach Hans, Zatloukal Kurt, Gorkiewicz Gregor
机构信息
Diagnostic and Research Institute of Pathology, Medical University of Graz, Neue Stiftingtalstrasse 6, 8010 Graz, Austria.
Alacris Theranostics GmbH, Max-Planck-Strasse 3, 12489 Berlin, Germany.
出版信息
iScience. 2022 Sep 16;25(9):104926. doi: 10.1016/j.isci.2022.104926. Epub 2022 Aug 13.
Secondary infections contribute significantly to covid-19 mortality but driving factors remain poorly understood. Autopsies of 20 covid-19 cases and 14 controls from the first pandemic wave complemented with microbial cultivation and RNA-seq from lung tissues enabled description of major organ pathologies and specification of secondary infections. Lethal covid-19 segregated into two main death causes with either dominant diffuse alveolar damage (DAD) or secondary pneumonias. The lung microbiome in covid-19 showed a reduced biodiversity and increased prototypical bacterial and fungal pathogens in cases of secondary pneumonias. RNA-seq distinctly mirrored death causes and stratified DAD cases into subgroups with differing cellular compositions identifying myeloid cells, macrophages and complement C1q as strong separating factors suggesting a pathophysiological link. Together with a prominent induction of inhibitory immune-checkpoints our study highlights profound alterations of the lung immunity in covid-19 wherein a reduced antimicrobial defense likely drives development of secondary infections on top of SARS-CoV-2 infection.
继发感染是导致新冠病毒肺炎(COVID-19)死亡的重要因素,但其驱动因素仍知之甚少。对20例COVID-19病例和14例第一波疫情期间的对照者进行尸检,并结合肺组织的微生物培养和RNA测序,得以描述主要器官病变并明确继发感染情况。致命性COVID-19主要分为两种死因,即主要为弥漫性肺泡损伤(DAD)或继发性肺炎。COVID-19患者的肺部微生物群显示生物多样性降低,继发性肺炎病例中原发性细菌和真菌病原体增加。RNA测序清晰地反映了死亡原因,并将DAD病例分为具有不同细胞组成的亚组,确定髓样细胞、巨噬细胞和补体C1q为强有力的区分因素,提示存在病理生理联系。连同抑制性免疫检查点的显著诱导,我们的研究突出了COVID-19中肺部免疫的深刻改变,其中抗菌防御能力下降可能在SARS-CoV-2感染之上推动继发感染的发展。
相似文献
iScience. 2022-9-16
Orv Hetil. 2021-11-7
Sci Rep. 2020-10-29
J Allergy Clin Immunol. 2021-4
引用本文的文献
Front Microbiol. 2025-5-30
Signal Transduct Target Ther. 2023-11-10
Clin Proteomics. 2022-12-17
本文引用的文献
Int J Mol Sci. 2021-12-24
Nucleic Acids Res. 2022-1-7
Biomedicines. 2021-8-12
Cancer Immunol Res. 2021-11
Curr Opin Infect Dis. 2021-8-1
Cell Host Microbe. 2021-7-14